LABCORP HOLDINGS INC. OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax
LABCORP HOLDINGS INC. (LH) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax · last filed 2018-02-27
- LABCORP HOLDINGS INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2016-03-31 was $0.00.
- LABCORP HOLDINGS INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- LABCORP HOLDINGS INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for the quarter ending 2014-03-31 was $6.30M.
- LABCORP HOLDINGS INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2017 was $0.00.
- LABCORP HOLDINGS INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2016 was $0.00.
- LABCORP HOLDINGS INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- LABCORP HOLDINGS INC. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment, tax for fiscal 2014 was $6.30M.
| Period end | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 3 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax 12 month |
|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-27 | |
| 2016-12-31 | $0.00 10-K · filed 2017-02-27 | |
| 2016-03-31 | $0.00 10-K · filed 2018-02-27 | |
| 2015-12-31 | $0.00 10-K · filed 2017-02-27 | |
| 2015-03-31 | $0.00 10-K · filed 2018-02-27 | |
| 2014-12-31 | $6.30M 10-K · filed 2016-03-01 | |
| 2014-03-31 | $6.30M 10-K · filed 2017-02-27 | |
| 2013-12-31 | -$6.30M 10-K · filed 2016-03-01 | |
| 2012-12-31 | $0.00 10-K · filed 2015-02-26 | |
| 2011-12-31 | $0.00 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |